ALIOF Stock UPDATES Actelion Ltd (ALIOF) 121.2780 09/09/2014

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Actelion Ltd (ALIOF) 121.2780 $ALIOF

Ligand Up on Multi-Program Captisol Deal with Avion Pharma - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Aug 18, 4:10PM CDT
Ligand Pharmaceuticals Incorporated (LGND) entered into a deal with Avion Pharmaceuticals, LLC, under which four Captisol-enabled programs will be developed and commercialized.

Achillion Pharmaceuticals Soars on Mid-Stage HCV Study Data - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Aug 18, 3:45PM CDT
Achillion Pharmaceuticals (ACHN) reported positive interim results from a phase II study on ACH-3102.

Gilead Scores Legal Victory Over Roche for Sovaldi, Shares Up - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Aug 18, 12:34PM CDT
Gilead (GILD) received a favorable verdict on Sovaldi.

TrovaGene (TROV) Worth Watching: Stock Rises 8.8% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Aug 18, 8:39AM CDT
TrovaGene, Inc. (TROV) was a big mover last session, as its shares rose almost 9% on the day.

NewLink Genetics Corp. (NLNK) Jumps: Stock Adds 8.6% in Session - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Aug 18, 7:51AM CDT
NewLink Genetics Corporation (NLNK) was a big mover last session, as its shares rose almost 9% on the day.

Achillion Pharmaceuticals (ACHN) in Focus: Stock Up 9.6% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Aug 18, 7:44AM CDT
Achillion Pharmaceuticals (ACHN) was a big mover last session, as the company saw its shares gain nearly 10% on the day.

Epizyme (EPZM) Crumbles: Stock Falls by 5.9% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Aug 18, 7:33AM CDT
Epizyme has been witnessing a flat movement in its earnings estimate front and its share price has been declining for past 24 hours

Amgen's FOCUS Study on Multiple Myeloma Drug Kyprolis Fails - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Aug 14, 4:20PM CDT
Amgen (AMGN) suffered a major setback when its phase III study, FOCUS on multiple myeloma treatment, Kyprolis did not meet its primary endpoint.

Genomic Health Raised to Buy on Better-than-Expected Q2 - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Aug 14, 11:10AM CDT
Genomic Health's (GHDX) sales grossed $70.5 million, up 10.7% year over year, exceeding the Zacks Consensus Estimate of $69 million

Halozyme Gains on Narrower-than-Expected Loss, Revenues Up - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Aug 14, 9:53AM CDT
The company's second quarter 2014 loss came in at 13 cents per share, narrower than the year-ago loss of 20 cents per share and the Zacks Consensus Estimate of a loss of 18 cents per share.

Insmed Incorporated (INSM) in Focus: Stock Up 10.9% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Aug 14, 8:39AM CDT
Insmed Incorporated (INSM) was a big mover last session, as its shares rose nearly 11% on the day.

InterMune (ITMN) Jumps: Stock Adds 14.4% in Session - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Aug 14, 7:51AM CDT
InterMune, Inc. (ITMN) was a big mover last session, as its shares rose over 14% on the day.

Dendreon Down on Default Risk, Reports Narrower Q2 Loss - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Aug 13, 1:37PM CDT
Shares of Dendreon Corporation (DNDN) were down significantly after the company warned that it will not be able to repay or refinance its notes due 2016.

BioDelivery Sciences Q2 Loss Narrows, Up on Solid Revenues - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Aug 13, 12:02PM CDT
Shares of BioDelivery Sciences International, Inc. (BDSI) jumped 7.58 % after the company reported its second-quarter 2014 results.

Myriad Genetics' Q4 Earnings Beat Estimates, Revenues Up Y/Y - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Aug 13, 8:40AM CDT
In the fourth quarter, Myriad Genetics' (MYGN) total revenue climbed 8.4% year over year to $188.8 million, beating the Zacks Consensus Estimate of $187 million by a whisker.

Intercept Pharmaceuticals (ICPT) Worth Watching: Stock Gains 16.6% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Aug 13, 8:25AM CDT
Intercept Pharmaceuticals (ICPT) was a big mover last session, with shares rising nearly 17% on the day.

Regeneron's Eye Drug Eylea Cleared in the EU for DME - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Aug 12, 4:20PM CDT
Regeneron's (REGN) Eylea has been approved for a third indication in the EU.

Sarepta Therapeutics Reports Wider Y/Y Loss, Revenues Miss - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Aug 12, 1:49PM CDT
Sarepta reported second quarter loss of 85 cents per share compared to a loss of 60 cents per share in the year-ago quarter.

MannKind Posts Wider Q2 Loss, Up on Sanofi Deal for Afrezza - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Aug 12, 10:05AM CDT
MannKind's (MNKD) loss of 19 cents per share was wider than the Zacks Consensus Estimate of a loss of 11 cents

OvaScience (OVAS) Shows Strength: Stock Up 7% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Aug 12, 8:39AM CDT
OvaScience, Inc. (OVAS) was a big mover last session, as its shares rose roughly 7% on the day.




Scroll down for more posts ▼

Top 10 Most Recent News Articles

SPOC Energy's Hiring Push Signals Growth Surge

Updated Category News Views 64

A Growing Workforce for a Growing Demand Here we are, smack dab in a bustling week of business news, and among it, SPOC Energy is ramping up its workforce across Alabama. Now, SPOC isn't any run-of-the-mill operation; this Birmingham-based manufacturer messes around with advanced power conversion systems and motor-control automation—a mouthful, sure, but critical stuff...

Continue Reading
Euroandinos Paita Closes Consent for 2037 Notes

Updated Category News Views 59

Port Strategy and Financial Implications Terminales Portuarios Euroandinos Paita S.A., nestled in the Peruvian transport sector, has been tight-rope walking through its debt landscape. Announcing a successful consent solicitation on November 13, 2026, they've taken a significant step towards reconfiguring their long-term financing game. This puppet show of paperwork...

Continue Reading
Terra Kaffe's Big Win with Oprah's Endorsement

Updated Category News Views 109

Terra Kaffe Hits the Jackpot with Oprah Sometimes, destiny has a way of handing out golden tickets, and for Terra Kaffe, receiving a nod from Oprah Winfrey's revered list of Favorite Things for 2026 is nothing short of that. I mean, you can't underestimate the pull Mrs. O has. Her endorsement isn’t just another celebrity pat-on-the-back, it’s a megaphone blaring...

Continue Reading
Webull Faces Class Action: Key Details for Investors

Updated Category News Views 22

What's Really Going on With Webull? When you hear there's a class-action lawsuit brewing, you know something's gone real sideways. Webull Corporation (NASDAQ: BULL) finds itself neck-deep in a securities fraud class action alleging some dicey dealings with China. If you've got skin in the game—and if you bought Webull stock between April 26, 2025, and October 6,...

Continue Reading
Pine AI Unveils AI Studio & Real-World Call Feature

Updated Category News Views 208

Push Your Expectations: Pine AI Takes the Stage Here's a twist in tech worth a double take. Pine AI is shaking up the AI world with a brash blend of video genius and actual chat capabilities. Somehow, merely weeks after setting the tech scene ablaze with its AI-focused computer, it's already rolling out new applications faster than hotcakes on a skillet. But let’s chew...

Continue Reading
Missoula Inventor Offers Handy Phone Solution on the Move

Updated Category News Views 97

Adjustable Convenience for the Modern Commuter When you're commuting or just lounging around, less hand strain and more comfort sounds like a no-brainer, right? Well, an inventive soul from Missoula, Montana, just might have cracked this little nut with a gizmo they're calling the COMMUTER PHONE. Imagine never having to juggle your phone during those bumpy moments on the...

Continue Reading
Eve Air Mobility's Vector System Proves Its Worth

Updated Category News Views 139

Eve Air Mobility's Vector system just pulled off something impressive at the Interlagos Circuit, showing it's not just a buzzword in the urban air mobility sphere. Picture this—over 100 helicopter flights in a day, all managed smoothly during one of the biggest motorsport events. That's the kind of action that gets investors to sit up and take notice of NYSE:EVEX....

Continue Reading
55 Broad Street's New Face: A $500M Revamp with RXR

Updated Category News Views 189

Recapitalization: Changing the Game for 55 Broad Street Here we are again, watching yet another iconic Manhattan building redefine itself. This time, it's 55 Broad Street's turn, as Silverstein, MetroLoft, and RXR shake things up. Newmark Group, Inc. (NASDAQ: NMRK), the fiery real estate power player, orchestrated a dynamic transaction involving a $305 million financing...

Continue Reading
Health Net Invests $3 Million in Stockton Housing

Updated Category News Views 115

Putting a Roof Over Stockton's Head The talk of the town in Stockton is Health Net stepping up with a $3 million investment. This isn't just dropping loose change in a jar; it's about tackling a mammoth issue—making affordable housing more than just a pipe dream for 75 families. Community-driven, they say. What a cozy way to paint a picture of bridging that brutal gap...

Continue Reading
Cardinal Infrastructure Faces Legal Scrutiny Amid Losses

Updated Category News Views 90

Cardinal Infrastructure Group Under Intense Investor Scrutiny Well, ain't this a messy soup of financial blunders? Cardinal Infrastructure Group (Nasdaq: CDNL) finds itself on the sharp end of a potential securities law investigation, thanks to some colossal screw-ups in managing project costs and estimates. Investors are rightly pissed after the company's shares...

Continue Reading

Top 5 Most Recently Viewed Articles

Dr. Mark Adams Takes the Helm as NDX's New President

Updated Category News Views 698

Dr. Mark Adams Takes the Helm as NDX's New President National Dentex Labs (NDX), a well-regarded provider of dental prosthetics and laboratory solutions, recently announced the appointment of Dr. Mark Adams as their new President. This strategic move positions the company for significant growth and innovation in the dental industry. Dr. Adams: A Proven Leader in Dentistry...

Continue Reading
Firefly Metals Secures C$30 Million Financing for Growth

Updated Category News Views 243

Firefly Metals Ltd Partners with BMO for Financing Firefly Metals Ltd (ASX: FFM, TSX: FFM), a rising star in the copper and gold sector, recently disclosed an agreement with BMO Nesbitt Burns Inc. This partnership is poised to solidify the company’s financial standing by instituting a bought deal financing arrangement, which is expected to yield C$30 million...

Continue Reading
Bird Construction Reports Impressive Q3 Growth and Impactful Acquisitions

Updated Category News Views 153

Bird Construction Achieves Remarkable Q3 Financial Results Bird Construction Inc. has recently shared robust financial outcomes for the third quarter, underscoring its growth and profitability trajectory. During this period, Bird Construction built on its earlier successes from the first half of the year, demonstrating solid momentum as it seeks a commendable finish to...

Continue Reading
KeyBank Partners with Zentist to Enhance Dental Revenue Cycles

Updated Category News Views 88

Understanding the Partnership Between KeyBank and Zentist Recently, KeyCorp (NYSE: KEY) formed a strategic partnership with Zentist, a well-regarded software provider that focuses on Insurance Revenue Cycle Management (RCM) for Dental Support Organizations (DSOs). This collaboration includes a minority investment designed to improve the financial operations of dental...

Continue Reading
Market Trends Shifting as Procter & Gamble Takes Center Stage

Updated Category News Views 306

Procter & Gamble: Analyzing Market Whales' Moves Recent trading activity surrounding Procter & Gamble (NASDAQ: PG) has captured the attention of financial analysts and investors alike. A remarkable bullish trend has emerged, as major traders initiate 16 unusual options trades reflecting confidence in this enduring brand. Understanding the Trader Sentiment Our assessment...

Continue Reading